APA (7th ed.) Citation

Conte, B., D'Alfonso, S., Mellai, M., Corà, D., Favero, F., Martini, V., . . . Gennari, A. (2025). 339P Transcriptomic profiling of circulating T lymphocytes predicts response to neoadjuvant therapy in patients with early breast cancer. Annals of Oncology, 36, S344. https://doi.org/10.1016/j.annonc.2025.08.768

Chicago Style (17th ed.) Citation

Conte, B., et al. "339P Transcriptomic Profiling of Circulating T Lymphocytes Predicts Response to Neoadjuvant Therapy in Patients with Early Breast Cancer." Annals of Oncology 36 (2025): S344. https://doi.org/10.1016/j.annonc.2025.08.768.

MLA (9th ed.) Citation

Conte, B., et al. "339P Transcriptomic Profiling of Circulating T Lymphocytes Predicts Response to Neoadjuvant Therapy in Patients with Early Breast Cancer." Annals of Oncology, vol. 36, 2025, p. S344, https://doi.org/10.1016/j.annonc.2025.08.768.